DAFTAR PUSTAKA

Akif, M., Masuyer, G., Schwager, S.L.U., Bhuyan, B.J., Mugesh, G., Issac, R.E.,
Sturrock, E.D., & Acharya, K.R., 2011, Structural characterization of
angiotensin I-converting enzyme in complex with a selenium analogue of
captopril, The Febs Journal, 278(19), 3644 - 3650.
Anderson, P.O., Knoben, J.E., and Troutman, W.G., 2002, Handbook of Clinical
Drug Data, 10th edition, , McGraw-Hill Companies, Inc., Sandego, California,
P:326-327.
Anonim, 1982. Captopril: evaluation of low doses, twice-daily doses and the addition
of diuretic for the treatment of mild to moderate hypertension. Veteran
administration cooperative study group on antihypertensive agent.Cooperative
Studies Program of the Veterans Administration Medical Research Service.
Clinical Science 63, 443s-445s.
Anonim,

2008.Angiotensin

Converting

Enzyme

(ACE)

Inhibitors.British

Hypertension Society.
Appel LJ et al. 2003.Effects Of Comprehensive Lifestyle Modification On
BloodPressure Control: Main Results Of The Premier Clinical Trial.
JAMA.289:2083-2093.
Armilawaty, Amalia H, dan Amirudin R, 2007, Hipertensi dan Faktor Risikonya
dalam Kajian Epidemiologi. Bagian Epidemiologi FKM UNHAS. Diakses 29
Januari,2014,<http;//www.CerminDuniaKedokteran.com/index.php?option=c
om_content&task=view&id=38&Itemid=12)>.
Badia, X., Roca-Cusachs, A., Dalfo, A., Gascon, G., Abellan, J., Lahoz, R., et
al.,2002. Validation of The Short Form of The Spanish Hypertension Quality
of Life Questionnaire (MINICHAL). Clin Ther.24(12): 2137-54.

86

Baharuddin, Kabo, P., Danny, S., 2013.Perbandingan Efektivitas dan Efek Samping
Obat Antihipertensi Terhadap Penurunan Tekanan Darah Pada Pasien
Hipertensi.Bagian

Farmakologi,

Fakultas

Kedokteran,

Universitas

Hasanuddin.
Bakris, G.L., 2007,

High Blood Pressure. The Merck Manual Home Health

Textbook, Diakses tanggal 29 Juli 2012,

<http://www.merckmanuals.com/home/heart_and_blood_vessel_disorders/hig
h_blood_pressure/high_blood_pressure.html?qt=&sc=&alt=#v717864>.
Brunner, H.R., Waebber, B., Nussberger, J., 1996, Angiotensin convert- ing enzyme
inhibitors. In: Messerli F, ed. Cardiovascular Drug Therapy, 2nd edn.
Philadelphia: W.B. Saunders: 670-700.
Campbell,B.,C.,Shepherd,A.N.,and
Reid,J.,L.,
1982.Effects
Oftheangiotensinconvertingenzymeinhibitor,captopril,inessential
hypertension.Br.J.clin.Pharmac.,13,213-217.
Carvalho, S.A.D., Silva, I.B.S., Ramos, S.B.P., Coelho, L.F., Goncalves, I.D., 2012.
Quality of Life of Hypertensive Patient and Comparasion of Two Instrumen of
HRQOL Measure.Universidade Federal do Maranhao-Sao Luiz, MA-Brazil.
Chapell, M.C., Yamaleyeva, L.M., and Westwood, B.M., 2006, Esterogen and Salt
Sensitivity in the Female mRen(2). Lewis Rat, Diakses Tanggan 10 April
2014,<http://ajpregu.physiology.org/cgi/reprint/281/6/R1934>.
Chobanian, A. V., Bakris, G. L.,Black, H. R., Cushman, W. C., Green, L. A., &
Joseph, L. I., 2003. The Seventh Report of the Joint National Committee on
Prevention, Detection, Evaluation, and Treatment of High Blood Preassure,
The U.S Departement of Health and Human Service, Boston.

87

Chobanian, A. V., et al., 2003. The Seventh Report of the Joint National Committee
on Prevention, Detection, Evaluation, and Treatment of High Blood
Preassure.JAMA.289:2560-2572.
Clark, E.M., 2003. Hypertension, in Clinical Pharmacy an Therapeutic. 247-258.
Harcourt Publisher. London.
Cramer, J. A.,& Spilker, B., 1998, Quality of Life and Pharmacoeconomics:dalam
Pharmacotherapy Handbook, 2nd Edition, Appleton and Lange, Stamford,
Connecticut, P: 94-113.
Cushman, D.W., Wang, F.L., Fung, W.C., Grover, G.J., Harvey, C.M, Scalese, R.J.,
Mitch, S.K., & DeForrest, J.M. (1989, April).Comparisons in vitro, ex vivio,
and in vivio of the actions of seven structurally diverse inhibitors of
angiotensin

converting

enzyme

(ACE).British

Journal

of

Clinical

Pharmacology, 28(S2), 115S - 130S.

Ct, I., Grgoire, J.P., Moisan, J., and Chabot,I., 2004., Quality of Life In
Hypertension: The SF-12 Compared To the SF-36, Diakses Tanggal 16 April
2014,<http://www.cjcp.ca/pdf/cjcp02-0015_e232.pdf>.
Depkes, 2006.Pharmaceutical Care Untuk Penyakit Hipertensi.Direktorat Bina
Farmasi Komunitas dan Klinik Ditjen Bina Kefarmasian dan Alat Kesehatan,
Jakarta, Departemen Kesehatan Republik Indonesia.
Depkes, 2013.Formularium Nasional.Diakses pada tanggal 3 April 2014,
<www.depkes.go.id/>.
Dinkes, 2012, Profil Kesehatan Provinsi Jawa Tengah tahun 2012, Yogyakarta,
Departemen Kesehatan Republik Indonesia, Provinsi Yogyakarta.
Dosh, S. A., 2001. The Diagnosis of Essensial and Secondary Hypertension in Adults.
J.Farm Pract:50:707-712.
88

Fahmiruddin, A., 2011. Studi Gejala Efek Samping Captopril Pada Pasien Hipertensi
Rawat Jalan Di Dumah Sakit Daerah dr. Soebandi Jember. Bagian
Komunitas dan Farmasi Klinis Fakultas Farmasi Jember.
Gomer, Beth., 2007, Farmakologi Hipertensi, Terjemahan Diana Lyrawati, 2008.
Penerbit Fakultas Kedokteran Universitas Indonesia. Jakarta.
Gray, H.H., Dawkins, K.D., Morgan, J.M., Sumpson, I.A., 2005. Lecture Notes
Cardiology. Edisi 4.EMS. Jakarta.
Gunawan, L., 2001.,Hipertensi : Tekanan darah tinggi. Yogyakarta: Percetakan
Kanisus; 2001.
Hairi, N.N., Hiong, T.G., Bulgiba, A., Mudla, I., 2012, Physical Fungtion in Older
People, Geriatrics, Prof. Craig Atwood (Ed.), ISBN: 978-953-51-0080-5, In
tech. diakses tanggal 20 Juni 2014,
<http://www.intechopen.com/books/geriatric/physical-fungtion-inolderpeople>.
He, J., 2000. Long-Term Effects Of Weight Loss And Dietary Sodium Reduction On
Incidence Of Hypertension. Hypertension;35:544-549.
Hu, Yu, and ZHU Junren, 1999.Quality of Life of Patients with Mild Hypertension
Treated With Captopril: a Randomized Double-Blind Placebo-Controlled
Trial. Chinese Medical Journal;112(4):302-307.
Ikawati, Z., Jumiani,S. dan Putu,I.D.P.S., 2008. Kajian Keamanan Pemakaian Obat
Antihipertensi di Poliklinik Usia Lanjut RS DR. Sardjito.Yogyakarta.Jurnal
Farmasi Indonesia Vol. 4 No. 1:30-41.
Israili, Z.H., Hall, W.D., 1992, Cough and angioneurotic edema associated with ACE
inhibitor therapy a review of the literature and pathophysiology. Ann
Intern Med;117: 234-42.

89

Jimbo, Masahito.,MD., 2009. Essential Hypertension, UMHS Hypertension

Guaideline, Guidelines for Clinical Care Ambulatory, Univesity of Michigan
Kabo, P., 2011. Bagaimana Menggunakan Obat-Obat Kardiovaskuler Secara
Rasional. Penerbit Fakultas Kedokteran Universitas Indonesia.
Kemenkes. 2013. Riset Kesehatan Dasar (RISKERDAS), Jakarta,Badan Penelitian
dan Pengembangan Kesehatan Kementerian Kesehatan Republik Indonesia.
Lacourciere, Y., Brunner, H.R., Irwin, R., Karlberg, B.E., Ramsay, L.E., 1994,
Effects of modulators of the renin-angiotensin aldoster- one system on cough.
J Hypertension;12: 1387-93.
Lees, K.R., Kelman, A.W., Reid, J.L., Whiting, B., 1989, Pharmacokinetic of an ACE
inhibitor S9780 in man: Evidence of tissue binding, J Pharmacokinet
Biopharm; 17: 529-50.
Lima, M.G., Barros, M.B.A., Cesar, C.L.G., Goldbaum, M., Carandina, L., Ciconelli,
R.M.,2009, Health related quality of life among the elderly: a population-base
study using SF-36 survey, Cad. Saude Publica, Rio de Jenero, 25(10):21592167.
Luigi, C.M.D., Maurizio, B.M.D., Paolo, V.M.D., Low dose Captopril Therapy in
Mild and Moderate Hypertension. Radomized Comparison of Twice day vs
three Times Daily Doses.Hypertension.5:III157. Hypertension is Published
by the American Heart Assosiation, Greenville Avenue, Dallas.
Malini PL, Strocchi E, Zanardi M, Milani M, Ambrosioni E., 1997. Thromboxane
antagonism and cough induced by angiotensin-converting enzyme inhibitor.
Lancet; 350: 1517.
Manolis, S. Kallistratos., 2010.Diagnostic Modalities of the Most Common Form of
Secondary

Hypertension.Cardiology
90

Department

and

Cardiovascular

Protection Clinic, Asklepeion Hospital, Athens, Greece. Hellenic J Cardiol;

51: 518-529.
Mansjoer, A., dkk, 2001.Kapita Selekta Kedokteran Jilid I :Nefrologi
danHipertensi.Jakarta: Media Aesculapius FKUI; 2001. p: 519-520.
Murphy, B. et al., 2000. Australian WHOQL-100, WHOQL-BREF and CA-WHOQL
INSTRUMENT; user manual and interpretation guide. Diakses pada14 Maret
2014, <http://www.psychiatry.unimelb.edu.au/>.
Natesh, R., Schwager, S.L.U., Evans, H.R., Sturrock, E.D., & Acharya, K.R., 2004,
Structural details on the binding of antihypertensive drugs captropril and
enalaprilat

to

human

testicular

angiotensin

I-converting

enzyme,

Biochemistry, 43, 8718 - 8724.

Oparil, S., et al., 2003.Pathogenesis of Hypertension. Ann Intern Med;139:761-776.
Paul, M., Mehr, A.P, & Kreutz, R., 2006, Physiology of Local Renin- Angiotensin
Systems, Physiological Reviews, 86(3), 747 803.
Prasetio,S.D,

dan

Chrisandyani,D.,

2009.

Gambaran

Efek

Samping

Obat

Antihipertensi pada Pasien Hipertensi di Instalasi Rawat Inap RS PKU

Muhammadiyah

Yogyakarta.diakses

oktober

2013,

<http://mf.farmasi.ugm.ac.id>.
Rahajeng, E., Tuminah, S., 2009.Prevalensi Hipertensi Dan Determinannya Di
Indonesia. Majalah Kedokteran Indonesia, Vol: 59, No: 12, Desember 2009.
Richer, C., Giroux, B.,Plouin, P., F.,Maarek, B., and Giudicelli, J.F. 1984.Captopril:
pharmacokinetics, antihypertensive and biological effects in hypertensive
patients. Br J Clin Pharmacol. Mar 1984; 17(3): 243250.

91

Ryan, J.W., Chung, A., Berryer, P., Murray, M.A., Ryan, J.P.A., 1986, Slow tight
binding inhibitors of angiotensin converting enzyme, Adv Exp Med Biol, 198:
419-25
Sassen, J.J., MacLaughlin, E.J., in Hypertension, Dipiro, J.T., Talbert, R.L., Yee,
G.C., Matzke, G.R., Wells, B.G., Posey, L.M., (Eds), 2008. Pharmacotherapy
A Pathiphysiologic Approach, seventh Edition, 139-172, McGraw Hill,
Medical Publishing Division, New York.
Schulz, R.B., Rossignoli, P., Corrner, C.J., Fernandes, L. F., Toni, P.M.,
2007.,Validation of The Short Form of The Spanish Hypertension Quality of
Life Questionnaire (MINICHAL) for Portuguese (Brazil). Universidade
Federal do Parana, Universidade Tuluti do Parana, Centro Universitario
Positivo, Universidade de Lisboa, Curitiba, PR- Brazil, Lisbon, Portugal, Arq
Bras Cardiol. 2008;90(2):127-131.
Spilker, B., 1996, Quality of Life and Pharmacoeconomics in Clinical Trial, 2nd
edition, 192-195, 517-8898 Lippincott-Raven Publisher, Philadelphia.
Susilo, Y., Wulandari, A., 2011. Cara Jitu Mengatasi Hipertensi, C.V Andi Offset,
Yogyakarta.
Swedberg, K., Held, P., Kjekshus, J., Rasmussen, P., Ryden, L., Weach, H., 1992,
Effects of early administration of enalapril in patients with acute myocardial
infarction' Results of the Cooperative New Scandinavian Enalapril Survival
Study II. N Engl J Med; 327: 678-84.
Testa, M. A., & Simonson, D. C., 1996, Assesment of Quality of Life Outcomes,
diaksespada08April2014,
<http://content.nejm.org/cgi/content/full/334/13/835>.

92

Vane, J.R., 1967, Conversion of Angiotensin I to Angiotensin II, Nature, 216, 762 766.
Weibert, R.T., dalam Herfindal, E.T., dan Gourley, D.R., 2000, Textbook of
Therapeutics: Drug and Disease Management, 7th edition, 795-820, Lippincot
Williams and Wilkins, USA.
Whelton P. K., 1998.Sosium Reduction And Weight Loss In The Treatment
OfHypertension In Older Persons: A Randomized, Controlled Trial Of
Nonpharmacologic Interventions In The Elderly.JAMA. 279:839-846.
WHO, 2011.Data Global Status Report on Communicable Diseases 2010.
Yogiantoro M., 2006. Hipertensi Esensial. Dalam Buku Ajar Ilmu Penyakit Dalam
Jilid I Edisi ke IV. Pusat Penerbitan Departemen Ilmu Penyakit Dalam.
Fakultas Kedokteran Universitas Indonesia. Jakarta: 610-14.

93